newsfilter
← Latest News
GlobeNewswire·

Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster Model

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenge